Viral leads for chemokine-modulatory drugs

Author： Lindow M.   Rudolf Luttichau H.   Schwartz T.W.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.3, 2003-03, pp. : 126-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-chemokine small molecule drugs: a promising future?

By Proudfoot Amanda EI   Power Christine A   Schwarz Matthias K  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 345-355

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Viral Conjunctivitis with Antiviral Drugs

By Skevaki Chrysanthi L.  

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite

Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines

By Sozzani S.   Allavena P.   Vecchi A.   Van Damme J.   Mantovani A.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 305-312

Elsevier

Access to resources Recommend Favorite

Mast Cell Cytokine and Chemokine Responses to Bacterial and Viral Infection

By  

Current Pharmaceutical Design, Vol. 9, Iss. 1, 2003-01 ,pp. : 11-24

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Different Proteins with GABAA Receptor and their Modulatory Effect on Inhibitory Neural Transmission Leads to Epilepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 7, 2014-09 ,pp. : 1148-1159

Bentham Science Publishers

Access to resources Recommend Favorite